Skytech Infinite Platform IPO
IPO Key Details
Price Band
₹73 to ₹77
Face Value
₹10 per share
Fresh Issue
27,96,800 shares (agg. up to ₹22 Cr)
Total Issue Size
29,45,600 shares (agg. up to ₹23 Cr)
Issue Type
Bookbuilding IPO
Exchange
NSE SME
Important Dates
IPO Open Date
Fri, Aug 14, 2026
IPO Close Date
Tue, Aug 18, 2026
Allotment Date
Wed, Aug 19, 2026
Listing Date
Fri, Aug 21, 2026
Skytech Infinite Platform Limited — company overview pending.
About the Company
⚠️ TODO — write from the RHP once uploaded. Do not copy from any website.
Company Strengths
⚠️ TODO — write from the RHP once uploaded.
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
| 1 | Working Capital Requirements | 16.81 |
| 2 | General Corporate Purposes | 3.40 |
| 3 | Issue Expenses | 2.47 |
| Total | 22.68 |
Financial Performance
| Period Ended | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
| Assets | 47.57 | 30.05 | 26.00 |
| Total Income | 52.14 | 45.21 | 44.15 |
| Profit After Tax | 4.20 | 3.71 | 1.35 |
| EBITDA | 6.65 | 6.13 | 3.09 |
| NET Worth | 19.02 | 14.81 | 11.10 |
| Reserves and Surplus | 12.14 | 7.94 | 10.48 |
| Total Borrowing | 9.25 | 5.39 | 3.90 |
| Amount in ₹ Crore |
GMP Today
⚠️ TODO — pull the current GMP figure once available.
IPO Reservation
| Investor Category | Shares | % of Net Issue | % of Total Issue |
| QIB | 28,800 | 1.03% | 0.98% |
| NII (HNI) | 13,72,800 | 49.08% | 46.61% |
| − bNII > ₹10L | 9,15,200 | 31.07% | |
| − sNII < ₹10L | 4,57,600 | 15.54% | |
| Retail | 13,95,200 | 49.89% | 47.37% |
| Firm Reservations | |||
| Market Maker | 1,48,800 | 5.05% | |
| Total | 29,45,600 | 100.00% | 100.00% |
Promoter Holding
⚠️ TODO — write from the RHP once uploaded.
Lead Managers
- Finshore Management Services Ltd.
Registrar and IPO Status
Registrar: Integrated Registry Management Services Pvt.Ltd.
Key Risk Factors
⚠️ TODO — write from the RHP once uploaded.
Frequently Asked Questions
⚠️ TODO — write from the RHP once uploaded.
Disclaimer
This page is meant only for informational and educational purposes. IPO investments are subject to market risks. Investors should read the DRHP/RHP and final offer document carefully and consult a financial advisor before making any investment decision.